Director · AbCellera Biologics Inc. · Common Shares
Side
BUY
Value
$178K
Shares
50.0K
Price
$3.57
Executed
Nov 26, 2025
Disclosed
Nov 26, 2025
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Nov 26 executedNov 26, 2025 disclosed
ABCL · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Montalbano John S. filed this Form 4 reporting a open-market purchase of ABCL on Nov 26, 2025. It became public on Nov 26, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Montalbano John S.cik:0001834423
Issuer
AbCellera Biologics Inc.cik:0001703057
Revision history · 0
No field has changed since this record was first ingested.
